Education
About Us
Working with TipRanks
Follow Us
Alnylam Pharmaceuticals (ALNY)
:ALNY
Alnylam Pharma (ALNY) Ownership Overview
0.42% Insiders
48.61% Mutual Funds
34.25% Other Institutional Investors
16.50% ETFs
0.22% Public Companies and
Individual Investors
The ownership structure of Alnylam Pharma (ALNY) stock is a mix of institutional, retail, and individual investors. Approximately 99.36% of the company’s stock is owned by Institutional Investors, 0.42% is owned by Insiders, and 0.22% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
Oct 03, 2025 | xxxxxxxxxxxxx | $1103451 | |
Oct 03, 2025 | xxxxxxxxxxxxx | $4034085 | |
Oct 03, 2025 | xxxxxxxxxxxxx | $1327675 | |
Oct 03, 2025 | xxxxxxxxxxxxx | $635126 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Sep 30, 2025 | xxxxxxxxxxxxx | $482448 | |
Sep 30, 2025 | xxxxxxxxxxxxx | $561336 | |
Sep 30, 2025 | xxxxxxxxxxxxx | $957600 | |
Sep 30, 2025 | xxxxxxxxxxxxx | $1374840 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 12,208,715 | Institution | 9.24% | 5,483,666,429 | |
| 11,794,683 | Institution | 8.93% | 5,297,699,816 | |
| 10,181,075 | Institution | 7.71% | 4,572,931,647 | |
| 5,199,295 | Institution | 3.94% | 2,335,315,342 | |
| 2,927,428 | Institution | 2.22% | 1,314,883,560 | |
| 2,442,141 | Institution | 1.85% | 1,096,912,052 | |
| 2,401,920 | Institution | 1.82% | 1,078,846,387 | |
| 2,389,919 | Institution | 1.81% | 1,073,456,018 | |
| 2,321,230 | Institution | 1.76% | 1,042,603,667 | |
| 2,171,613 | Institution | 1.64% | 975,401,695 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 11,794,683 | Institution | 8.93% | 5,297,699,816 | |
| 10,181,075 | Institution | 7.71% | 4,572,931,647 | |
| 2,927,428 | Institution | 2.22% | 1,314,883,560 | |
| 2,442,141 | Institution | 1.85% | 1,096,912,052 | |
| 2,401,920 | Institution | 1.82% | 1,078,846,387 | |
| 2,389,919 | Institution | 1.81% | 1,073,456,018 | |
| 2,171,613 | Institution | 1.64% | 975,401,695 | |
| 1,604,154 | Institution | 1.21% | 720,521,811 | |
| 1,598,800 | Institution | 1.21% | 718,117,008 | |
| 1,577,494 | Institution | 1.19% | 708,547,205 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 4,129,434 | Institution | 3.13% | 1,883,021,904 | |
| 2,899,813 | Institution | 2.19% | 1,322,314,728 | |
| 1,607,287 | Institution | 1.22% | 732,922,872 | |
| 1,403,301 | Institution | 1.06% | 639,905,256 | |
| 1,123,196 | Institution | 0.85% | 512,177,376 | |
| 838,694 | Institution | 0.63% | 376,707,797 | |
| 820,753 | Institution | 0.62% | 368,649,417 | |
| 591,619 | Institution | 0.45% | 268,577,277 | |
| 489,743 | Institution | 0.37% | 219,972,966 | |
| 451,601 | Institution | 0.34% | 202,841,105 |
FAQ
Who Owns Alnylam Pharmaceuticals (ALNY)?
According to the latest TipRanks data, approximately 34.25% of the company's stock is held by institutional investors, 0.42% is held by insiders, and 0.22% is held by retail investors.
What percentage of Alnylam Pharmaceuticals (ALNY) stock is held by institutional investors?
According to the latest TipRanks data, approximately 34.25% of Alnylam Pharmaceuticals (ALNY) stock is held by institutional investors.
What percentage of Alnylam Pharmaceuticals (ALNY) stock is held by retail investors?
According to the latest TipRanks data, approximately 0.22% of Alnylam Pharmaceuticals (ALNY) stock is held by retail investors.
Who owns the most shares of Alnylam Pharmaceuticals (ALNY)?
Vanguard owns the most shares of Alnylam Pharmaceuticals (ALNY).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.